XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
9 Months Ended
Sep. 30, 2023
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS  
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

4. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

The Company’s cash equivalents and short-term investments are invested in the following (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

September 30, 2023

​

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

​

$

63,671

​

$

—

​

$

—

​

$

63,671

Total cash equivalents

​

​

63,671

​

​

—

​

​

—

​

​

63,671

Total short-term investments

​

​

—

​

​

—

​

​

—

​

​

—

Total cash equivalents and short-term investments

​

$

63,671

​

$

—

​

$

—

​

$

63,671

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

December 31, 2022

​

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

​

$

51,274

​

$

—

​

$

—

​

$

51,274

Total cash equivalents

​

​

51,274

​

​

—

​

​

—

​

​

51,274

Commercial paper

​

​

39,781

​

​

—

​

​

—

​

​

39,781

Corporate bonds

​

​

28,970

​

​

—

​

​

(156)

​

​

28,814

U.S. Treasury securities

​

​

19,896

​

​

—

​

​

(78)

​

​

19,818

Government bonds

​

​

14,846

​

​

—

​

​

(102)

​

​

14,744

Asset-backed securities

​

​

4,000

​

​

—

​

​

(2)

​

​

3,998

Total short-term investments

​

​

107,493

​

​

—

​

​

(338)

​

​

107,155

Total cash equivalents and short-term investments

​

$

158,767

​

$

—

​

$

(338)

​

$

158,429

​

During the year ended December 31, 2021, the Company made a $20.0 million investment in equity securities of a publicly-traded company. The Company records this investment at fair value within short-term investments, which was $0.8 million as of September 30, 2023. During the three and nine months ended September 30, 2023, the Company recorded unrealized losses of $0.1 million and $0.3 million, respectively, due to the change in fair value of the equity securities. During the three and nine months ended September 30, 2022, the Company recorded unrealized losses due to the change in fair value of the equity securities of $0.3 million and $6.2 million, respectively, in interest and other (expense) income, net in the consolidated statements of operations.